These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28807919)

  • 1. Drug Susceptibility and Replicative Capacity of Multidrug-Resistant Recombinant Human Cytomegalovirus Harboring Mutations in
    Piret J; Goyette N; Boivin G
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by
    Chou S; Satterwhite LE; Ercolani RJ
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
    Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
    Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
    Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
    J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy.
    Chou S
    J Clin Virol; 2011 Apr; 50(4):287-91. PubMed ID: 21295516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance.
    Chou S; Ercolani RJ; Lanier ER
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3845-8. PubMed ID: 27044553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient.
    Jung S; Michel M; Stamminger T; Michel D
    BMC Infect Dis; 2019 May; 19(1):388. PubMed ID: 31068147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds.
    Chou S
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates.
    Scott GM; Weinberg A; Rawlinson WD; Chou S
    Antimicrob Agents Chemother; 2007 Jan; 51(1):89-94. PubMed ID: 17043128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
    Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
    J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection.
    Cherrier L; Nasar A; Goodlet KJ; Nailor MD; Tokman S; Chou S
    Am J Transplant; 2018 Dec; 18(12):3060-3064. PubMed ID: 30286286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.
    Cihlar T; Fuller MD; Cherrington JM
    J Virol; 1998 Jul; 72(7):5927-36. PubMed ID: 9621055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance.
    Chou S
    Antiviral Res; 2017 Dec; 148():1-4. PubMed ID: 29107686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant cytomegalovirus: clinical implications of specific mutations.
    Razonable RR
    Curr Opin Organ Transplant; 2018 Aug; 23(4):388-394. PubMed ID: 29794552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus.
    James SH; Price NB; Hartline CB; Lanier ER; Prichard MN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3321-5. PubMed ID: 23650158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
    Chou S; Ercolani RJ; Sahoo MK; Lefterova MI; Strasfeld LM; Pinsky BA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4697-702. PubMed ID: 24890586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.